Our Mission is to develop innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders in order to reduce the burden on patients and their caregivers.
Intra-Cellular Therapies is a biopharmaceutical company founded on Paul Greengard’s Nobel-prize winning research that uncovered how therapies affect the inner-working of cells in the body.
We leverage this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic disease. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all we do create and deliver.
Management Team Photo Courtesy of Alexandria Real Estate Equities, Inc.